company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,150000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,150000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,150000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,194000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,661000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,855000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-705000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-721000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-721000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-721000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-721000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3600000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3600000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3672885.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q2,2013-04-01,2013-06-30,2014-09-11 19:27:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,258000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,550000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,808000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-778000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-813000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-813000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-813000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-813000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3673000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:03:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,726000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,910000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1636000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1606000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-43000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-57000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1663000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1663000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1663000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1663000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3673000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,135000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,135000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,135000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1494000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4588000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4453000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,208000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-433000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-641000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,3230000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8324000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.27
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.27
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3673000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:14:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.27
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,204000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,204000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,204000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2398000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5746000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8144000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7940000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-316000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-316000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8256000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8256000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8256000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8256000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16500000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16500000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16394000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:34:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3380000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7226000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10606000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10403000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10391000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10391000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10391000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10391000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11600000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.76
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11600000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.76
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11651000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4143000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5621000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9764000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9561000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,52000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,52000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9509000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9509000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9509000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9509000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24887000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4959000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5126000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10085000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9882000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,116000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,116000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9766000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9766000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9766000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9766000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25555000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:59:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,953000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,953000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,953000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7631000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7523000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15154000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14201000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,117000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,117000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14084000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14084000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14084000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14084000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25600000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25600000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25685000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:24:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,960000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,960000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,960000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5374000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7192000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2573000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15139000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14179000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,85000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,85000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25500000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25500000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25479000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,265000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,265000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,265000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8318000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7455000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15773000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15508000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,116000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,116000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15392000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15392000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15392000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15392000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.57
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.57
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27095000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.57
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,307000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,307000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,307000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5114000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7955000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,49120000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62189000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-61882000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,222000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,222000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61660000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61660000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61660000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61660000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.76
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.76
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35044000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:01:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.76
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,395000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,395000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,395000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6146000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8362000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,394000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14902000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14507000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,206000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,206000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14301000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14301000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14301000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14301000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40900000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40900000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41416000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:21:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,488000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,488000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,488000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4777000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7898000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23875000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23387000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,218000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,218000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23169000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-775000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22394000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22394000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22394000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36246000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,462000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,462000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,462000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7989000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9061000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17050000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16588000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,489000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,489000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16099000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16099000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16099000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16099000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42400000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42400000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42144000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,463000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,463000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,463000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4064000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8492000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12556000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12093000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,663000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,663000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11430000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11430000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11430000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11430000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42300000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42300000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43009000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:24:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,463000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,463000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,463000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4762000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10272000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15034000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14571000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,742000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,742000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13829000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13829000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13829000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13829000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43381000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:21:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,461000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,461000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,461000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4042000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12014000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16056000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15595000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,806000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,806000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14789000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14789000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14789000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14789000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43500000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43500000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43661000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,216000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,216000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,216000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5368000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12794000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18162000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17946000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,746000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,746000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57300000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57300000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57420000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,493000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,493000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,493000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9179000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11217000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20396000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19903000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1093000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1093000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18810000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18810000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18810000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18810000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62366000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:07:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,833000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,833000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,833000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4826000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14480000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,5000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24306000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23473000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1265000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1265000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22208000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1250000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20958000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20958000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20958000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61600000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61600000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62454000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:24:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,70000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,70000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,70000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5187000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11642000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16829000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16759000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1100000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1100000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15659000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15659000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15659000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-168000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15491000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61400000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61400000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61375000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5576000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10131000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15707000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15707000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1218000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1218000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14489000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14489000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14489000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-3000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14486000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63125000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7132000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8970000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16102000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16102000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1148000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1148000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14954000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14954000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14954000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14954000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63740000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:07:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,250000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,250000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,250000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7389000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9944000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17333000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17083000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,965000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,965000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16118000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16118000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16118000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16118000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64500000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64500000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64484000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:24:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8279000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11374000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19653000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19653000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,728000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,728000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18925000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18925000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18925000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-30000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18895000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63800000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63800000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64102000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
